ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,859.85
      0.77%
      US Tech 100
      19,858.00
      -0.21%
      Dow Jones
      43,065.22
      0.47%
      Brent Oil
      73.86
      -1.40%
      Bitcoin
      65,651.17
      -0.61%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adaptive Biotechnologies Corporation (ADPT)

      7. Adaptive Biotechnologies Corporation (ADPT) Financials

      Adaptive Biotechnologies Corporation

      Adaptive Biotechnologies Corporation (ADPT)

      Adaptogenics Health Corp
      4.95
      0.01
      (0.20%)
      Closed October 14 4:00PM
      Delayed by 15 minutes
      4.95
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Adaptive Biotechnologies Corporation Financial Summary

      The current ADPT market cap is 729.99M. The company's latest EPS is USD -1.5274 and P/E is -3.24.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 37.65M48.93M37.92M45.78M41.87M
      Operating Income -57.19M-47.82M-50.96M-45.64M-48.76M
      Net Income -57.7M-47.81M-50.3M-69.44M-47.51M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 85.07M98.38M154.34M185.31M170.28M
      Operating Income -78.39M-152.82M-208.97M-200.19M-201.61M
      Net Income -69.57M-146.23M-207.28M-200.19M-225.25M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 791.46M764.54M717.68M661.13M620.32M
      Total Liabilities 367.51M368.57M356.05M352.86M345.56M
      Total Equity 423.95M395.97M361.64M308.28M274.77M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 912.3M1.12B923.34M856.62M661.13M
      Total Liabilities 341.26M373.15M319.24M392.52M352.86M
      Total Equity 571.04M743.27M604.1M464.1M308.28M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -59.15M-82.71M-129.39M-156.32M-38.35M
      Investing 62.98M100.3M126.44M129.65M44.51M
      Financing 672k2.14M2.16M2.25M44k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 205.4M-149.68M-192.73M-183.95M-156.32M
      Investing -481.7M-117.04M181.21M2.91M129.65M
      Financing 319.92M293.59M27.15M132.27M2.25M

      Stats and Ratios

      Market Cap 729.99M
      Price to Earnings Ratio -3.24
      Price to Sales Ratio 4.29
      Price to Cash Ratio 11.22
      Price to Book Ratio 2.37
      Dividend Yield -

      Share Statistics

      Shares Outstanding 147.47M
      Average Volume (1 week) 791.53k
      Average Volume (1 Month) 1.18M
      52 Week Change 16.75%
      52 Week High 5.795
      52 Week Low 2.28
      Spread (Intraday) 0.76 (13.57%)

      Company Info

      Company Name Adaptive Biotechnologies Corporation
      Address 711 capitol way s ste 204
      olympia, washington 98501 1267
      Website https://www.adaptivebiotech.com
      Industry biological pds,ex diagnstics (2836)

      Your Recent History

      NASDAQ
      ADPT
      Adaptive Biotechnologies
      Delayed Upgrade Clock